세계의 폴리에틸렌 글리콜(PEG) 시장 : 등급별, 형상별, 패키지 사이즈별, 최종 이용 산업별, 지역별 - 예측(-2029년)

The PEG market is projected to reach USD 5.31 Billion By 2029, At A CAGR Of 6.2% From USD 3.94 Billion in 2024. PEG have versatile applications among various end-use industries including pharmaceuticals. PEG are widely used for drug formulations and delivery systems in pharmaceutical industries. It enhances the solubility and bioavailability of poorly soluble drugs. Additionally, due to its low toxicity and non-irritating properties it is widely used in cosmetics & personal care industries for manufacturing various products such as creams, lotions and bath gels.

"Based on grade, PEG 400 accounts for the fastest market during the forecast period, in terms of value."

PEG 400 accounts for the fastest market during the forecast period due to its versatility of applications across various range of industries including pharmaceuticals and cosmetics & personal care. This grade of PEG has low molecular weight and high hydrophilicity. These properties make it an effective lubricant for enhancing the solubility and bioavailability in drug formulations and drug delivery systems. Moreover, it is used for manufacturing of oral, topical, and injectable formulations due to its low toxicity which fuels the market growth. Additionally, due to its non-irritating and biodegradable nature it is highly used in cosmetics and personal care industry acting as humectant, lubricant and solvents for different products such as creams, lotions and bath gels.

"Based on package size, bulk container is the largest market during the forecast period, in terms of value."

Bulk containers account for the largest market by package size due to several factors. In industrial applications such as pharmaceuticals and cosmetics & personal care require large quantities of PEG for efficient manufacturing processes. The packaging in bulk containers minimizes the handling and storage costs required for small containers offering cost effective storage for manufacturers. Moreover, using of bulk containers enhance the supply chain efficiency by minimizing the frequency of PEG deliveries for industrial applications. Furthermore, bulk containers minimize the waste of material as it requires less packaging material compared to smaller containers. Collectively, these factors contribute to making bulk containers account largest share by package size in PEG market.

"Based on region, Asia Pacific is the largest and fastest growing market for PEG, in terms of value."

Asia Pacific is the largest and fastest growing region for PEG market. The region has rapidly expanding pharmaceutical, cosmetics & personal care and other industries particularly in countries like China and India. The demand for PEG in various applications such as drug formulation, delivery systems, cosmetics and chemical formulation is rising in the region. Additionally, the region's growing population has resulted into expansion of healthcare boosting the consumption of PEG in pharmaceutical industries. The rising disposable income of people is fueling the use of PEG in cosmetics & personal care products. Furthermore, the presence of major manufacturers, low production costs and favorable government policies accelerate the market growth in the region. As the region continues to industrialize and urbanize, the PEG market is anticipated to grow in the Asia pacific region.

In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-Level - 35%, Director Level - 25%, and Others - 40%
• By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, Rest of World - 11%

The key players in this market are BASF (Germany), Dow (US), Clariant (Switzerland), Lotte Chemical Corporation (South Korea), Sanyo Chemicals Industries Ltd (Japan), Sabic (Saudi Arabia), Kao Corporation (Japan), Croda International Plc (UK), India Glycols Limited (India), INEOS (India), Merck KGaA (Germany), Indorama Ventures Public Company Limited (Thailand), NOF Corporation (Japan) and Spectrum Chemical (US).

Research Coverage

This report segments the PEG market based on grade, form, end-use industry, package size and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers & acquisitions associated with the PEG market.

Key benefits of buying this report

This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the PEG market, high-growth regions, and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Growing demand for medicines, advancement in drug delivery technologies, expansion of cosmetics & personal care, rising prevalence of chronic diseases), restraints (Fluctuating raw material prices, environmental safety and issues, concerns over immunogenicity), opportunities (Expansion of personalized medicines, increasing demand for long-acting medications, 3-D printing and bio fabrication) and challenges (Product performance limitations, degradation Issues).
• Market Penetration: Comprehensive information on the PEG market offered by top players in the global PEG market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the PEG market.
• Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for PEG market across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global PEG market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the PEG market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 UNITS CONSIDERED
• 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Primary interviews-demand and supply side
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of interviews with experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 GROWTH FORECAST
• 2.4 DATA TRIANGULATION
• 2.5 FACTOR ANALYSIS
• 2.6 ASSUMPTIONS
• 2.7 LIMITATIONS & RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN POLYETHYLENE GLYCOL MARKET
• 4.2 POLYETHYLENE GLYCOL MARKET, BY FORM
• 4.3 POLYETHYLENE GLYCOL MARKET, BY GRADE
• 4.4 POLYETHYLENE GLYCOL MARKET, BY PACKAGE SIZE
• 4.5 POLYETHYLENE GLYCOL MARKET, BY END-USE INDUSTRY
• 4.6 POLYETHYLENE GLYCOL MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing demand for medicines for chronic disease management
    • 5.2.1.2 Advancements in drug delivery technologies
    • 5.2.1.3 Expansion of cosmetics and personal care industries
    • 5.2.1.4 Growing demand for bio-based polyethylene glycol
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Fluctuating raw material prices
    • 5.2.2.2 Environmental safety and issues
    • 5.2.2.3 Concerns over immunogenicity
    • 5.2.2.4 Competition from substitute products
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing demand for personalized medicines for biologics and precision therapies
    • 5.2.3.2 Innovations in 3D printing and bio-fabrication
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limitations related to product performance
    • 5.2.4.2 Degradation issues concerning polyethylene-based drug formulations
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT FROM NEW ENTRANTS
  • 5.3.2 THREAT FROM SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.4.2 QUALITY
  • 5.4.3 SERVICE
• 5.5 MACROECONOMIC OUTLOOK
  • 5.5.1 GDP TRENDS AND FORECASTS
• 5.6 IMPACT OF AI/GENAI
• 5.7 VALUE CHAIN ANALYSIS
  • 5.7.1 RAW MATERIAL SUPPLIERS
  • 5.7.2 MANUFACTURERS
  • 5.7.3 DISTRIBUTORS
  • 5.7.4 END USERS
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 REGULATORY LANDSCAPE
  • 5.9.1 ENVIRONMENTAL REGULATIONS
  • 5.9.2 NORTH AMERICA
  • 5.9.3 ASIA PACIFIC
  • 5.9.4 EUROPE
  • 5.9.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 TECHNOLOGY ANALYSIS
  • 5.10.1 KEY TECHNOLOGIES
    • 5.10.1.1 Smart PEGylation
    • 5.10.1.2 Nanotechnology
    • 5.10.1.3 Controlled-release drug delivery
  • 5.10.2 COMPLEMENTARY TECHNOLOGIES
    • 5.10.2.1 PEG hydrogels in bioprinting
    • 5.10.2.2 Random polyethylene glycol
• 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.12 TRADE ANALYSIS
  • 5.12.1 IMPORT SCENARIO (HS CODE 291010)
  • 5.12.2 EXPORT SCENARIO (HS CODE 291010)
  • 5.12.3 IMPORT SCENARIO (HS CODE 340420)
  • 5.12.4 EXPORT SCENARIO (HS CODE 340420)
• 5.13 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.14 PRICING ANALYSIS
  • 5.14.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2029
  • 5.14.2 AVERAGE SELLING PRICE TREND, BY END-USE INDUSTRY, 2023
  • 5.14.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END-USE INDUSTRY, 2023
• 5.15 INVESTMENT AND FUNDING SCENARIO
• 5.16 PATENT ANALYSIS
  • 5.16.1 INTRODUCTION
  • 5.16.2 DOCUMENT TYPES
  • 5.16.3 PUBLICATION TRENDS IN LAST 10 YEARS
  • 5.16.4 INSIGHTS
  • 5.16.5 LEGAL STATUS
  • 5.16.6 JURISDICTION ANALYSIS
  • 5.16.7 TOP APPLICANTS
• 5.17 CASE STUDY ANALYSIS
  • 5.17.1 UNILEVER DEVELOPS SKINCARE FORMULATIONS TO ENHANCE MOISTURIZING EFFECT AND BOOST BRAND LOYALTY
  • 5.17.2 BASF DEVELOPS POLYURETHANE FOAMS TO REDUCE HEAT LOSS IN BUILDINGS AND IMPROVE CUSHIONING IN AUTOMOBILE SEATS
  • 5.17.3 MERCK KGAA DEVELOPES DRUG DELIVERY SYSTEMS TO ENHANCE BIOAVAILABILITY OF TARGETED THERAPEUTIC MOLECULES

6 POLYETHYLENE GLYCOL MARKET, BY FORM

• 6.1 INTRODUCTION
• 6.2 LIQUID
  • 6.2.1 USED AS HUMECTANT AND EMULSIFIER FOR RETAINING MOISTURE AND STABILIZING FORMULATIONS
• 6.3 WHITE WAX SOLID
  • 6.3.1 EXTENSIVE USE IN DERMATOLOGICAL APPLICATIONS
• 6.4 FLAKE/POWDER
  • 6.4.1 WIDE APPLICATIONS IN SOLID AND SEMI-SOLID FORMULATIONS

7 POLYETHYLENE GLYCOL MARKET, BY GRADE

• 7.1 INTRODUCTION
• 7.2 PEG 200
  • 7.2.1 EXCELLENT WATER SOLUBILITY ENSURING UNIFORM DISTRIBUTION OF ACTIVE PHARMACEUTICAL INGREDIENTS
• 7.3 PEG 400
  • 7.3.1 WIDELY PREFERRED IN PHARMACEUTICAL INDUSTRY TO IMPROVE MOISTURE RETENTION AND ENHANCE TEXTURE
• 7.4 PEG 1000
  • 7.4.1 HIGH DEMAND IN COSMETICS AND DRUG FORMULATIONS TO ENHANCE SOLUBILITY AND BIOAVAILABILITY OF DRUGS
• 7.5 PEG 3350
  • 7.5.1 WIDELY USED AS OSMOTIC LAXATIVE IN PHARMACEUTICAL INDUSTRY
• 7.6 PEG 4000
  • 7.6.1 INCREASING DEMAND IN CONTROLLED DRUG DELIVERY SYSTEMS TO IMPROVE OVERALL PRODUCT STABILITY
• 7.7 PEG 6000
  • 7.7.1 WIDE APPLICATION AS BINDER AND THICKENING AGENT IN TABLET AND CAPSULE FORMULATIONS
• 7.8 PEG 8000
  • 7.8.1 EXTENSIVE USE IN BIOMEDICAL APPLICATIONS AND ELASTOMER FORMATION
• 7.9 OTHER GRADES

8 POLYETHYLENE GLYCOL MARKET, BY PACKAGE SIZE

• 8.1 INTRODUCTION
• 8.2 DRUMS
  • 8.2.1 WIDELY USED FOR PEG 200 AND PEG 400 IN LARGE-SCALE PHARMACEUTICAL APPLICATIONS
• 8.3 BULK CONTAINERS
  • 8.3.1 REDUCE FREQUENCY OF REORDERING AND MINIMIZE PACKAGING WASTE
• 8.4 GLASS BOTTLES
  • 8.4.1 INCREASING DEMAND IN PHARMACEUTICAL AND COSMETIC INDUSTRIES
• 8.5 OTHER PACKAGE SIZES

9 POLYETHYLENE GLYCOL MARKET, BY END-USE INDUSTRY

• 9.1 INTRODUCTION
• 9.2 PHARMACEUTICAL
  • 9.2.1 RISING DEMAND FOR POLYETHYLENE GLYCOL IN DRUG DELIVERY SYSTEMS TO DRIVE MARKET
• 9.3 COSMETICS & PERSONAL CARE
  • 9.3.1 PRESSING NEED FOR EXTENDING SHELF LIFE OF COSMETIC FORMULATIONS TO BOOST DEMAND
• 9.4 FOOD & BEVERAGE
  • 9.4.1 WIDE APPLICATIONS IN FOOD PROCESSING AND PRESERVATION TECHNIQUES TO DRIVE MARKET
• 9.5 INDUSTRIAL
  • 9.5.1 INCREASING DEMAND IN METALWORKING AND PLASTIC PRODUCTION TO DRIVE MARKET
• 9.6 OTHER END-USE INDUSTRIES

10 POLYETHYLENE GLYCOL MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 US
    • 10.2.1.1 Robust demand from pharmaceutical industry to drive market
  • 10.2.2 CANADA
    • 10.2.2.1 Innovations and technological advancements to drive market
  • 10.2.3 MEXICO
    • 10.2.3.1 Favorable regulatory environment for trade to increase demand for polyethylene glycol
• 10.3 ASIA PACIFIC
  • 10.3.1 CHINA
    • 10.3.1.1 Rising investments in healthcare to fuel market
  • 10.3.2 INDIA
    • 10.3.2.1 Rapid population and industrial growth to drive market
  • 10.3.3 JAPAN
    • 10.3.3.1 Innovation in biologics and personalized medicines to drive market
  • 10.3.4 SOUTH KOREA
    • 10.3.4.1 Growth of cosmetics & personal care industry to boost demand for polyethylene glycol
  • 10.3.5 INDONESIA
    • 10.3.5.1 Expansion of healthcare sector to drive market
  • 10.3.6 AUSTRALIA
    • 10.3.6.1 Increasing investments in drug developments to drive market
  • 10.3.7 REST OF ASIA PACIFIC
• 10.4 EUROPE
  • 10.4.1 GERMANY
    • 10.4.1.1 Pressing need for injectables and laxatives to drive market
  • 10.4.2 UK
    • 10.4.2.1 Expansion of pharmaceutical and healthcare companies to drive market
  • 10.4.3 FRANCE
    • 10.4.3.1 Rise in elderly population to boost demand for advanced healthcare solutions
  • 10.4.4 ITALY
    • 10.4.4.1 Expansion of cosmetics & personal care industry to drive market
  • 10.4.5 SPAIN
    • 10.4.5.1 Increasing consumer spending on cosmetics & personal care products to drive market
  • 10.4.6 REST OF EUROPE
• 10.5 MIDDLE EAST & AFRICA
  • 10.5.1 GCC
    • 10.5.1.1 Saudi Arabia
      • 10.5.1.1.1 Rise in infrastructural development to boost market
    • 10.5.1.2 UAE
      • 10.5.1.2.1 Rapid industrial expansion to drive demand for polyethylene glycol
    • 10.5.1.3 Rest of GCC
  • 10.5.2 SOUTH AFRICA
    • 10.5.2.1 Rising chronic disease rate to boost demand for effective drug formulations
  • 10.5.3 REST OF MIDDLE EAST & AFRICA
• 10.6 SOUTH AMERICA
  • 10.6.1 BRAZIL
    • 10.6.1.1 Diverse applications in end-use industries to drive market
  • 10.6.2 ARGENTINA
    • 10.6.2.1 Improving economic conditions to drive demand
  • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019-2024
• 11.3 REVENUE ANALYSIS, 2021-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND/PRODUCT COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Grade footprint
    • 11.7.5.4 End-use industry footprint
    • 11.7.5.5 Form footprint
    • 11.7.5.6 Package size footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of key startups/SMEs
• 11.9 COMPETITIVE SCENARIO AND TRENDS
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS
  • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 DOW
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Solutions/Services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 BASF
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Solutions/Services offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 CLARIANT
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Solutions/Services offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 LOTTE CHEMICAL CORPORATION
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Solutions/Services offered
    • 12.1.4.3 MnM view
      • 12.1.4.3.1 Key strengths
      • 12.1.4.3.2 Strategic choices
      • 12.1.4.3.3 Weaknesses and competitive threats
  • 12.1.5 SANYO CHEMICALS INDUSTRIES LTD.
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Solutions/Services offered
    • 12.1.5.3 MnM view
      • 12.1.5.3.1 Key strengths
      • 12.1.5.3.2 Strategic choices
      • 12.1.5.3.3 Weaknesses and competitive threats
  • 12.1.6 SABIC
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Solutions/Services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Others
    • 12.1.6.4 MnM view
  • 12.1.7 KAO CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Solutions/Services offered
    • 12.1.7.3 MnM view
  • 12.1.8 CRODA INTERNATIONAL PLC
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Solutions/Services offered
    • 12.1.8.3 MnM view
  • 12.1.9 INDIA GLYCOLS LIMITED
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/services/solutions offered
  • 12.1.10 INEOS
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/services/solutions offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Expansions
  • 12.1.11 MERCK KGAA
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Solutions/Services offered
  • 12.1.12 INDORAMA VENTURES PUBLIC COMPANY LIMITED
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Solutions/Services offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
  • 12.1.13 NOF CORPORATION
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Solutions/Services offered
  • 12.1.14 AVESTA PHARMA PVT. LTD.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Solutions/Services offered
    • 12.1.14.3 Recent developments
    • 12.1.14.4 MnM view
      • 12.1.14.4.1 Key strengths
      • 12.1.14.4.2 Strategic choices
      • 12.1.14.4.3 Weaknesses and competitive threats
  • 12.1.15 SASOL
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Solutions/Services offered
    • 12.1.15.3 MnM view
      • 12.1.15.3.1 Key strengths
      • 12.1.15.3.2 Strategic choices
      • 12.1.15.3.3 Weaknesses and competitive threats
  • 12.1.16 OXITENO
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products/Solutions/Services offered
    • 12.1.16.3 Recent developments
    • 12.1.16.4 MnM view
      • 12.1.16.4.1 Key strengths
      • 12.1.16.4.2 Strategic choices
      • 12.1.16.4.3 Weaknesses and competitive threats
• 12.2 OTHER PLAYERS
  • 12.2.1 SPECTRUM CHEMICAL
  • 12.2.2 KRAFT CHEMICAL COMPANY
  • 12.2.3 LIAONING KELONG FINE CHEMICAL CO., LTD.
  • 12.2.4 SHANGHAI BRONKOW CHEMICAL CO., LTD.
  • 12.2.5 LIAONING SHENGDE HUAXING CHEMICAL CO. LTD.
  • 12.2.6 JIANGSU HAI'AN PETROCHEMICAL PLANT
  • 12.2.7 CHEMICAL BULL
  • 12.2.8 HUNAN HUATENG PHARMACEUTICAL CO., LTD.
  • 12.2.9 MATANGI INDUSTRIES
  • 12.2.10 LAYSAN BIO
  • 12.2.11 CREATIVE PEGWORKS
  • 12.2.12 JENKEM TECHNOLOGY
  • 12.2.13 YIXING CLEANWATER CHEMICALS CO., LTD.
  • 12.2.14 LIAONING OXIRANCHEM

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 RELATED REPORTS
• 13.4 AUTHOR DETAILS 2901 INTRODUCTION